Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNexus Gene Lab (BGLC) Interest Coverage Ratio (2021 - 2025)

BioNexus Gene Lab's Interest Coverage Ratio history spans 5 years, with the latest figure at 108.38 for Q3 2025.

  • For Q3 2025, Interest Coverage Ratio rose 49.82% year-over-year to 108.38; the TTM value through Sep 2025 reached 75.65, down 81.04%, while the annual FY2024 figure was 74.42, 60.03% up from the prior year.
  • Interest Coverage Ratio for Q3 2025 was 108.38 at BioNexus Gene Lab, up from 125.29 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 89.48 in Q2 2023 and bottomed at 593.69 in Q3 2023.
  • The 5-year median for Interest Coverage Ratio is 28.18 (2024), against an average of 78.81.
  • The largest YoY upside for Interest Coverage Ratio was 250.41% in 2023 against a maximum downside of 1986.25% in 2023.
  • A 5-year view of Interest Coverage Ratio shows it stood at 11.39 in 2021, then soared by 167.13% to 7.64 in 2022, then soared by 122.49% to 17.01 in 2023, then tumbled by 265.69% to 28.18 in 2024, then plummeted by 284.64% to 108.38 in 2025.
  • Per Business Quant, the three most recent readings for BGLC's Interest Coverage Ratio are 108.38 (Q3 2025), 125.29 (Q2 2025), and 125.98 (Q1 2025).